Published by Josh White on 9th February 2026
(Sharecast News) - Avacta Therapeutics announced the appointment of Francis Wilson as its chief scientific officer on Monday, effective immediately, as the AIM-traded clinical-stage biopharmaceutical company prepared for further development of its 'preCISION' tumour-activated oncology delivery platform.
URL: http://www.digitallook.com/dl/news/story/35686455/...